Academic Clinical Trials Program
Leukemia & Lymphoma Society
UM Funding ID
FD03672
Sponsor
Leukemia & Lymphoma Society
Program
Category
International
Description
The LLS ACT initiative is a clinical trial award program designed to develop cutting edge treatments that will have meaningful impact for blood cancer patients.
These awards will fund clinical trials, up to $1M USD over a period of up to three years.
Both the LOI and the Full Application must be submitted electronically to the LLS Research Portal.
Results Announced: April 2025
VPRI Contact
Michelina Violi
Research Grants Specialist (Health & International)Michelina [dot] .Violi [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 01-Aug-2024 3:00 pm EST |
Application (Upon Invitation Only) | 05-Sep-2024 4:30 pm CST | 16-Sep-2024 3:00 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.